数据链接：
官方服务：
资源简介：
Examples of predicted synergistic novel drug pairs.
应用场景：
创建时间：
2021-02-12
相关数据集
Table_1_Combinatorial Strategies to Target Molecular and Signaling Pathways to Disarm Cancer Stem Cells.docx
Cancer is an urgent public health issue with a very huge number of cases all over the world expected to increase by 2040. Despite improved diagnosis and therapeutic protocols, it remains the main lead
NIAID Data Ecosystem130
Chrysin-Enhanced Cytotoxicity of 5-Fluorouracil-Based Chemotherapy for Colorectal Cancer in Mice: Investigating its Effects on Cyclooxygenase-2 Expression
Abstract 5-fluorouracil (5-FU) has been recognized as an effective medication used to treat colorectal cancer (CRC); however, its administration is facing limitations due to some complications reporte
DataCite Commons2022-06-09 更新70
The antimalarial drug mefloquine enhances TP53 premature termination codon readthrough by aminoglycoside G418
Nonsense mutations constitute ~10% of TP53 mutations in cancer. They introduce a premature termination codon that gives rise to truncated p53 protein with impaired function. The aminoglycoside G418 ca
Figshare2019-05-23 更新40
Uncovering the dosage-dependent roles of Arid1a in gastric tumorigenesis for combinatorial drug therapy [RNA-Seq]
Gastric cancer (GC) is one of the most common deadly cancers in the world. Although patient genomic data have identified ARID1A, a key chromatin remodeling complex subunit, as the second most frequent
NIAID Data Ecosystem80
Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells
Sensitization of mismatch repair (MMR)-deficient colorectal cancer (CRC) cells by 5-Fluorouracil (5-FU) is well-documented. But not much is known about the treatment of MMR-proficient CRC cancer stem
DataCite Commons2023-10-30 更新70
